cPass™ SARS-CoV-2 Neutralizing Antibody Testing
May 5, 2021
Presenters: Laura Peek, Ph.D., Biodesix
Sean Taylor, MBA, Ph.D. GenScript
Biodesix will be launching the cPass™ SARS-CoV-2 Neutralizing Antibody Test as part of our WorkSafe COVID-19 Testing Program in the coming months.
To learn more about developing a WorkSafe program with Biodesix or partnering for research or development purposes, contact us or call (866) 432-5930.
- SARS-CoV-2 Neutralizing Antibody Testing for Vaccine Efficacy Assessment ( Download)
- SARS-CoV-2 Neutralizing Antibody Testing for Vaccine Efficacy Assessment ( Download)
- SARS-CoV-2 neutralizing antibody test for evaluating neutralizing antibody prevalence in Singapore ( Download)
- Measurement of COVID19 neutralization antibodies titers in infected/recovered/vaccinated individuals ( Download)
- A high throughput test for detecting neutralizing antibodies to SARS-CoV-2 ( Download)
- cPass™ SARS CoV 2 Neutralizing Antibody (NAb) test for post vaccination monitoring ( Download)
- Detection of SARS-CoV-2 Neutralizing Antibodies with GenScript's SARS-CoV-2 Surrogate Virus... ( Download)
- Webinar on SARS-COV-2 Neutralizing Antibody Test ( Download)
- Contrasting total IgG binding assays with a high-throughput SARS-CoV-2 neutralizing antibody test ( Download)
- How-to: A Step-by-Step Guide to the SARS-CoV-2 Neutralizing antibody Test (LFIA) - Medomics Medical ( Download)
- Webinar - Streamline your SARS CoV 2 Antibody Testing with a sVNT NAb Solution ( Download)
- Measuring levels of neutralizing antibodies in SARS CoV-2 infected/recovered & vaccinated... ( Download)
- Antibody Responses in COVID 19 - Implications for Understanding Antibody Testing ( Download)
- cPass™ SARS-CoV-2 Neutralizing Antibody test for vaccine development and immunity status monitoring ( Download)
- cPass SARS-COV-2 neutralization antibody kit by GenScript ( Download)
